1-3 of 3
Alejandro Yovine
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tumor Mutational Burden as a Predictor of Survival with Durvalumab and/or Tremelimumab Treatment in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Sophie Wildsmith, Weimin Li, Song Wu, Ross Stewart, Nassim Morsli, Rajiv Raja, Qu Zhang, Jiabu Ye, Philip He, Jagdish Shetty, Alejandro Yovine, Nicholas Holoweckyj, Katia Real, Jill Walker, Magdalena Wrona, Melissa de los Reyes, Craig Barker, Jessica Whiteley, Robert Haddad, Lisa Licitra, Robert Ferris, Jérôme Fayette, Dan P. Zandberg, Lillian L. Siu, Ricard Mesía
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (11): 2066–2074.
https://doi.org/10.1158/1078-0432.CCR-22-2765
Published: 01 June 2023
View articletitled, Tumor Mutational Burden as a Predictor of Survival with Durvalumab and/or Tremelimumab Treatment in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Open the PDF for Tumor Mutational Burden as a Predictor of Survival with Durvalumab and/or Tremelimumab Treatment in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

Targeting FGFR with Dovitinib (TKI258): Preclinical and Clinical Data in Breast Cancer

Fabrice André, Thomas Bachelot, Mario Campone, Florence Dalenc, Jose M. Perez-Garcia, Sara A. Hurvitz, Nicholas Turner, Hope Rugo, John W. Smith, Stephanie Deudon, Michael Shi, Yong Zhang, Andrea Kay, Diana Graus Porta, Alejandro Yovine, José Baselga
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (13): 3693–3702.
https://doi.org/10.1158/1078-0432.CCR-13-0190
Published: 30 June 2013
View articletitled, Targeting FGFR with Dovitinib (TKI258): Preclinical and Clinical Data in Breast Cancer
Open the PDF for Targeting FGFR with Dovitinib (TKI258): Preclinical and Clinical Data in Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Phase I and Pharmacokinetic Study of Irofulven Administered Weekly or Biweekly in Advanced Solid Tumor Patients

Jérôme Alexandre, Eric Raymond, Mahmoud Ould Kaci, Etienne C. Brain, François Lokiec, Carmen Kahatt, Sandrine Faivre, Alejandro Yovine, François Goldwasser, Sheri L. Smith, John R. MacDonald, Jean-Louis Misset, Esteban Cvitkovic
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (10): 3377–3385.
https://doi.org/10.1158/1078-0432.CCR-03-0349
Published: 24 May 2004
View articletitled, Phase I and Pharmacokinetic Study of Irofulven Administered Weekly or Biweekly in Advanced Solid Tumor Patients
Open the PDF for Phase I and Pharmacokinetic Study of Irofulven Administered Weekly or Biweekly in Advanced Solid Tumor Patients in another window